Reprogene is a clinical genetics facility, independently and privately owned that is CLIA and state certified, specializing in detecting human chromosomal abnormalities, genetic diseases and disorders. Our industry is evolving rapidly to promise a healthier future for reproductive genetics, the fastest growing segment. With international recognition through patented technologies and a growing number of clients, Reprogene always maintains the most innovative technologies to keep up with global demands.

If you are interested in the possibility of becoming an investor, please contact us at investor@reprogene.net